相关实验视频
Updated: Jun 13, 2025

07:25
Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
22.1K
对酸环酶受体NPR1的抗体调节血管度
Michael E Dunn1, Aaron Kithcart2, Jee Hae Kim2
1Regeneron Pharmaceuticals, Tarrytown, NY, USA. michael.dunn@regeneron.com.
Nature
|September 11, 2024
概括
尿酸性受体1 (NPR1) 基因的遗传变异影响心力衰竭的风险. 一种新的抗体,REGN5381,可以选择性地降低静脉压力,为心力衰竭患者提供潜在的新疗法.
科学领域:
- 心血管医学
- 药理学
- 遗传学
背景情况:
- 心脏衰竭是导致疾病和死亡的主要原因.
- 尿酸及其受体 (NPR1) 在调节血压和液体平衡方面发挥作用.
- 由于效果持续时间短,使用尿酸的现有治疗方法存在局限性.
研究的目的:
- 研究NPR1基因变异与心力衰竭风险之间的关联.
- 开发和评估一种针对NPR1受体治疗心力衰竭的新疗法.
主要方法:
- 人类基因分析超过70万个.
- 开发REGN5381,一个针对NPR1受体的单克隆激动抗体.
- 在动物模型和健康的志愿者中评估REGN5381的血液动力学效应.
主要成果:
- 终身接触NPR1基因变异与血压变化和心力衰竭风险有关.
- 在动物模型中,REGN5381可优化降低静脉压和静脉压.
- 在人体中,REGN5381诱导了预期的血液动力学效应,降低了静脉压力,但没有显著改变尿液或自然尿液.
结论:
- 对NPR1功能的遗传洞察为新的心力衰竭治疗提供了基础.
- 在心力衰竭中选择性降低静脉压力的长期治疗剂REGN5381具有前景.
- 支持进一步开发REGN5381用于控制由静脉压力升高导致的心力衰竭症状.
更多相关视频
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
Antihypertensive Drugs: Vasodilators
491
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
491
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
606
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
606
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K

